Conservest Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
Conservest Capital Advisors's AMGN Position: Q2 2026 in Review
Conservest Capital Advisors increased its Amgen (AMGN) stake by 3.1% in Q2 2026, buying an estimated $11.3K and bringing the position to 1,083 shares worth $392K. The position accounts for 0.03% of the portfolio, ranked #96.
Conservest Capital Advisors first reported a position in AMGN in Q1 2017 and has held it in 28 quarters since. The position peaked at $586K in Q3 2017. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Conservest Capital Advisors held 1,083 shares of Amgen worth $392K as of Q2 2026.
- Conservest Capital Advisors bought 33 Amgen shares in Q2 2026, an estimated $11.3K.
- Amgen made up 0.03% of Conservest Capital Advisors's portfolio in Q2 2026, its #96 holding.
- Conservest Capital Advisors first reported a position in Amgen in Q1 2017 and has held it in 28 quarters since.
- Conservest Capital Advisors's Amgen position peaked at $586K in Q3 2017.
- 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Conservest Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.